The 23^rd^ World Congress of Dermatology (WCD) was an extraordinary event with more than 11,000 delegates from 116 countries assembled in the vibrant coastal seaport of Vancouver, British Columbia, Canada. It was a grand congress, enhanced with 271 sessions, 4562 individual presentations, and 3788 abstracts, plus many International League of Dermatological Societies (ILDS), member societies, and ancillary groups hosting their own half- or full-day meetings. WCD President Jerry Shapiro (Canada) and Secretary-General Harvey Lui (Canada) welcomed the attendees \[[Figure 1](#F1){ref-type="fig"}\] and accentuated the WCD\'s rich tradition as the planet\'s oldest continuous international dermatology meeting, commencing in Paris in 1889.
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Many superb presentations were given in the program, adroitly crafted by Jean Bolognia (USA), Chair of the ILDS/WCD 2015 Scientific Program Committee. Patrick S Moore (USA), co-discoverer of two of the seven known human cancer viruses, Kaposi\'s sarcoma herpes virus, and Merkel cell polyomavirus, delivered a distinguished lecture on skin cancer and viruses. John McGrath (United Kingdom of Great Britain and Northern Ireland) lauded next generation sequencing as enhancing discovery of new genes and causative mutations for inherited skin diseases in his keynote lecture. Sandipan Dhar (India) stressed the use of oral corticosteroids and cyclosporine for otherwise uncontrollable atopic dermatitis, favoring steroids use for a maximum of 4 weeks or cyclosporine for up to 6 months. Zbigniew Ruszczak (Abu Dhabi) grouped granuloma faciale and eosinophilic folliculitis as disorders with predominant involvement of eosinophils, lamenting that neither has standardized treatment. Wilma Bergfeld (USA) delineated hirsutism as a possible presenting sign of polycystic ovary syndrome, metabolic syndrome, and insulin resistance, with early diagnosis and therapy of abnormal androgens possibly diminishing the long-term side effects of chronic androgen excess. Branka Marinovic (Croatia) stressed systemic corticosteroids in a starting dose of 0.5--0.75 mg/kg/day as therapy of choice in patients with bullous pemphigoid. Roberto Arenas (Mexico) emphasized *Mycobacterium lepromatosis* as a newly discovered cause of leprosy. John Kelly (Australia) noted that nodular melanoma, desmoplastic melanoma, and acral lentiginous melanoma represent only 15% of melanomas, but cause half of melanoma deaths. Ricardo Romiti (Brazil) proclaimed that paraneoplastic dermatomyositis may be the first sign of visceral cancer or of its relapse, with adults having dermatomyositis sine myositis at increased cancer risk. Łukasz Matusiak and Jacek Szepietowski (Poland) proposed chitinase-3-like protein 1 as a possible new biomarker for hidradenitis suppurativa.

Additional state-of-the-art lectures were also memorable. Torello M Lotti (Italy) highlighted mycobacterial infections in the immunosuppressed patients. Pierre Wolkenstein (France) noted that toxic epidermal necrolysis involves cytotoxic T cells and suggested cyclosporine therapy might decrease its mortality. Robert A Schwartz (USA) evinced that the Drug Reaction with Eosinophilia and Systemic Symptoms syndrome may be evident with an acute necrotizing eosinophilic myocarditis sometimes developing months after withdrawal of the offending drug and resolution of the cutaneous eruption. Margarita Larralde (Argentina) characterized the eccrine angiomatous hamartoma as a rare tumor, usually evident since birth and that may be tender and show excessive sweating. Gerd Plewig (Germany) categorized demodex mites as the only permanent human ectoparasites and as arachnids that in the immunocompromised may cause folliculitis and abscesses.

Luminaries were abundant \[Figures [1](#F1){ref-type="fig"}--[5](#F5){ref-type="fig"}\]. Delegates of ILDS member societies from many countries, including India as represented by Venkataram Mysore \[[Figure 2](#F2){ref-type="fig"}\], Indonesia by M Yulianto Listiawan, Kuwait by Abdulwahab S Al-Fouzan \[[Figure 4](#F4){ref-type="fig"}\], Dubai by Ibraham Galadari \[[Figure 4](#F4){ref-type="fig"}\], and Egypt by Assem Farag \[[Figure 4](#F4){ref-type="fig"}\] expressed support for the efforts of the ILDS, voted to have the 24^th^ WCD in 2019 in Milan, Italy, and joined attendees in congratulating ILDS President Wolfram Sterry, incoming ILDS President Harvey Lui, and Scientific Program Committee Chair Jean Bolognia, for helping make this 23^rd^ WCD a smashing success.
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